FEB 19, 2020 7:10 AM PST

Testing the Immune Response to Ovarian Cancer Treatment

WRITTEN BY: Kara Marker

There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean better diagnostics, and better diagnostics lead to catching cases of ovarian sooner, improving treatment options and prognoses.

The new diagnostic test was assessed in a recent clinical trial conducted in two cohorts of women with advanced ovarian cancer from two hospitals in Melbourne, Australia.

The new diagnostic test quantifies the body’s immune response to potential ovarian tumors by testing the blood for cancer markers as well as a specific immune biomarker for inflammation – interleukin (IL)-6. The presence of these biomarkers can help differentiate harmless ovarian cysts from malignant epithelial ovarian cancer. The most common form of ovarian cancer begins in the epithelial cells (GHR).

The new test is, according to senior author and chief investigator Magdalena Plebanski, “as accurate as the combined results of a standard blood test and ultrasound.” Utilizing the new diagnostic test eliminates need for MRI scans or ultrasounds. Improving the way women are diagnosed with ovarian cancer could reduce the number of needless operations, as women with harmless cysts would know they don’t need surgical removal.

 “This is especially important for women in remote or disadvantaged communities, where under-resourced hospitals may not have access to complex and expensive equipment like ultrasound machines or MRI scanners,” Plebanski added.

While the current study only included women with advanced ovarian cancer, future clinical trials testing the accuracy of this new test could include women with earlier stages of ovarian cancer.

About Ovarian Cancer

Ovarian cancer is one of the most common gynecologic cancers. Every year, 300,000 new cases of ovarian cancer are diagnosed across the world. 60 percent of women die within five years of diagnosis.

Sources: RMIT University, Scientific Reports

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 28, 2020
Drug Discovery & Development
Could the Blood of Coronavirus Survivors Save Lives?
MAR 28, 2020
Could the Blood of Coronavirus Survivors Save Lives?
As the search for a treatment for coronavirus continues, a perhaps obscure-sounding candidate has begun to make headline ...
APR 07, 2020
Immunology
Too Much Salt Is Bad for the Immune System
APR 07, 2020
Too Much Salt Is Bad for the Immune System
Excessive salt intake is associated with health consequences for more than just cardiovascular status; the immune system ...
APR 09, 2020
Drug Discovery & Development
4 Natural Antihistamines with No Side Effects
APR 09, 2020
4 Natural Antihistamines with No Side Effects
Over-the-counter antihistamine treatments are known to be effective for relieving allergic symptoms. However, they are a ...
MAY 07, 2020
Cell & Molecular Biology
How the Function of a Critical Immune Cell is Related to Metabolism
MAY 07, 2020
How the Function of a Critical Immune Cell is Related to Metabolism
This work suggests that it may be possible to dampen autoimmunity or promote an immune attack on cancer through a bioche ...
MAY 13, 2020
Drug Discovery & Development
Fecal Transplant Helps Fight off Antibiotic Resistance
MAY 13, 2020
Fecal Transplant Helps Fight off Antibiotic Resistance
Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has ...
JUL 07, 2020
Immunology
Existing drugs can prevent SARS-CoV-2 from hijacking cells
JUL 07, 2020
Existing drugs can prevent SARS-CoV-2 from hijacking cells
An international team of researchers has analysed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins i ...
Loading Comments...